Articles by December, 2024

  The global radiation injury drugs market is anticipated to grow at a significant CAGR 4.5% during the forecast period (2024-2031). Radiation injury is defined as the damage of tissues due to exposure of ionizing radiation. The ionizing radiation given in large dose may injure the healthy human cells and even result in acute illness leading to decrease in the production of blood cells and harm the gastrointestinal tract. It also results in the damage to cardiovascular health, blood vessels, brain and especially skin. The major factor attributable to the market growth include the high prevalence of cancer patients globally who further opt for the radiation therapy. For instance, as per the International Agency for Research on Cancer, in 2020, there were 19.3 million cases of cancer globally and 10 million died due to cancer. Thus, this surge in the cancer patients is likely to drive the global radiation injury drugs market growth.  Get Free Sample link @ https://www. ... Continue reading →

The global coronary guidewires market is anticipated to grow at a significant CAGR 5.9% during the forecast period (2024-2031). Coronary guidewires are specialized pieces of equipment. They are used to deliver therapies to diseased areas of the coronary arterial system. These guidewires have the properties of steerability, traceability, flexibility and are used in minimally invasive surgeries. The major factor driving the demand for coronary guidewires is the rising number of minimally invasive surgeries along with the increasing prevalence of cardiovascular diseases (CVDs) across the globe. Get Free Sample link @ https://www.omrglobal.com/request-sample/coronary-guidewires-market According to the World Health Organization (WHO), CVDs are the leading cause of mortality globally with a mortality rate of an estimated 17.9 million people in 2019 which represented 32% of all global mortalities. Additionally, out of these, 85% were due to heart attack and stroke. Furthermore, in the same ... Continue reading →

The global high potency active pharmaceutical ingredient (HPAPI) market is anticipated to grow at a considerable CAGR during the forecast period (2024-2031). The major factor driving the demand for the global high potency active pharmaceutical ingredients (HPAPI) market during the forecast period is the increasing demand for these drugs across the globe. The global HPAPI market is growing especially after the COVID-19 pandemic due to which governments focus on pharmaceutical raw materials like high potency active ingredients which drive the growth of the market.  Get Free Sample link @ https://www.omrglobal.com/request-sample/high-potency-active-pharmaceutical-ingredients-hpapi-market Furthermore, targeted therapy is getting popular as compared to drugs or chemotherapy as it does not harm non-cancerous cells. Moreover, the growth of the market is also attributed to the increasing prevalence of cancer. According to the National Cancer Institute (NCI), it was estimated ... Continue reading →

The global incretin-based drugs market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2024-2031). Increased research activity, government initiatives to promote disease awareness, and research grants are primary factors which are expected to fuel the global incretin-based drug market’s growth over the forecast period. Furthermore, rising government spending in R&D activities, as well as new product releases by numerous prominent companies, are expected to further propel the diabetes medicines market. Get Free Sample link @ https://www.omrglobal.com/request-sample/incretin-based-drugs-market For instance, in October 2021, Glenmark launched drug in combination of various incretin based drug types including remogliflozin, vildagliptin, metformin fixed-dose combination (FDC) at an affordable cost for adults with type-2 diabetes. Among others, India is the first country to get access to this FDC drug. Glenmark had received an approval ... Continue reading →

The global levofloxacin market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2024-2031). A major element driving market expansion is hospital-acquired infection (HAI). Pneumonia, bloodstream infection, surgical site infection, and urinary tract infection are among the most frequent hospital-acquired infections. Government regulations to prevent and control hospital infections, the need for disinfectants and disposable safety goods to reduce the danger of infectious microorganisms will increase. For instance, in 2018, the Centers for Disease Control and Prevention (CDC) estimates that roughly 2 million people in the US are infected with hospital-acquired diseases each year. The growth of the levofloxacin market is also driven by an increase in the global geriatric population, as well as an increase in the prevalence of chronic and infectious diseases. Lack of physical activity, unsanitary conditions, and lifestyle changes will all ... Continue reading →

  The global lixisenatide market is anticipated to grow at a considerable CAGR during the forecast period (2024-2031). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in June 2021, Novo Nordisk received US Food and Drug Administration (FDA) approval of Wegovy (semaglutide) injection for chronic weight management in adults with obesity with one weight-related condition such as high blood pressure, type-2 diabetes, or cholesterol. Furthermore, in June 2019, Novo Nordisk has received US Food and Drug Administration Approval of expanded use of Victoza injection to lower the blood sugar along with diet and exercise in children and adolescents aged 10-17 years with type-2 diabetes. The Victoza also plays a major role in reducing the risk of ... Continue reading →

The global lutein and zeaxanthin market is anticipated to grow a considerable CAGR during the forecast period. Key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in April 2019, Dohler Group acquired the majority of shares in Zumos Catalano Aragoneses S.A (ZUCASA). Moreover, ZUCASA consists of more than 24,000 square meters over an area of 168,000 square meters owing to the capacity to store 32000 m3 of natural juices and concentrates. Thus, Dohler stated that customers will benefit from more diversity in stone fruit segments as well as in apples and pears.  Get Free Sample link @ https://www.omrglobal.com/request-sample/lutein-and-zeaxanthin-market Furthermore, in June 2019, DDW Inc. acquired Du Pont's natural color business. The CEO ... Continue reading →

  The global meniscal rasps market is anticipated to grow at a significant CAGR 8.7% during the forecast period (2024-2031). Meniscal rasps provide the additional benefit of reduced healing time and plays important role in arthroscopic surgery of the knee involving meniscal tear. Arthroscopic surgeries that involve meniscal rasps are minimally invasive surgery. Hence, they are preferred as curative treatment of meniscal tears due to less healing time. The market is growing due to the increasing awareness about the benefits of meniscal rasps in arthroscopic surgeries as well as significant efforts by the key manufacturers in the global meniscal rasps market. Additionally, based on type, the market is subsegment into manual meniscal rasps and electric meniscal rasps. The manual meniscal rasp is anticipated to hold a prominent share in the market owing to the convenience of handling. Furthermore, by end-user, hospitals hold a prominent share in the market due to the high number ... Continue reading →

Oral dissolvable films market is anticipated to grow at a significant CAGR 8.9% during the forecast period (2024-2031). Orally dissolving films (ODFs) are also known as oral thin films. It provides a quick release of an active pharmaceutical ingredient (API) when placed on the tongue without the intake of water and is used as an alternative to orally disintegrating tablets. It is a kind of drug delivery system.  The major factor driving the demand for oral dissolvable films is the new product launches and approvals across the globe. Get Free Sample link @ https://www.omrglobal.com/request-sample/oral-dissolvable-films-market For instance, in February 2022, Aquestive Therapeutics, Inc. announced the opening of its Investigational New Drug Application (IND) for the drug AQST-109 from the U.S. Food and Drug Administration (FDA). AQST-109  is an epinephrine oral film used for the treatment of anaphylaxis. Moreover, the market is also growing owing to the growing applications of ... Continue reading →

The global resection guides market is anticipated to grow at a significant CAGR 5.3% during the forecast period (2024-2031). Resection is the medical term used for surgically removing a part or all of a tissue, structure or organ and is performed for a wide variety of reasons. It may remove a tissue that is cancerous or diseased. The surgery may treat or cure a disease process. The major factor driving the demand for resection guides is the rising number of surgeries across the globe. Get Free Sample link @ https://www.omrglobal.com/request-sample/resection-guides-market Moreover, the market is also growing due to the new product launches by the players in the market. For instance, in November 2021, Stryker announced the launch of the Prophecy Infinity Resect-Through Guides. It is used for total ankle replacement surgeries and represents the latest refinement of Stryker’s industry gold standard technique that allows surgeons to improve OR efficiency. Additionally, North ... Continue reading →